Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 39 (NPM1P39) is a genomic DNA sequence related to the NPM1 gene but has lost the ability to code for a functional protein, primarily due to accumulated mutations and lack of necessary regulatory regions[2][6]. Pseudogenes such as NPM1P39 are classified by their origin (processed or unprocessed), and while some pseudogenes have been shown to modulate gene expression or participate in gene regulatory networks, NPM1P39 itself does not possess documented functional, regulatory, or disease associations distinct from its parent gene, nucleophosmin 1 (NPM1)[2][6][8]. Its relevance is mainly genomic, with potential—but unproven—roles in gene regulation by mechanisms such as miRNA sponging or gene conversion. It is not a protein, enzyme, transporter, or receptor, nor is it a known drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 39 (NPM1P39).